| Q36633772 | Bench-to-bedside review: Erythropoietin and its derivatives as therapies in critical care |
| Q37627225 | Carbohydrate analysis throughout the development of a protein therapeutic |
| Q46567387 | Changes in conformation and stability upon formation of complexes of erythropoietin (EPO) and soluble EPO receptor |
| Q36311658 | Characterization of a monoclonal antibody to human erythropoietin |
| Q39918037 | Construction and characterization of stably transfected BHK-21 cells with human-type sialylation characteristic |
| Q28362976 | Development and characterization of novel erythropoiesis stimulating protein (NESP) |
| Q38756381 | Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesis |
| Q54173895 | Epoetin beta pegol, but not recombinant erythropoietin, retains its hematopoietic effect in vivo in the presence of the sialic acid-metabolizing enzyme sialidase. |
| Q37098040 | Erythropoietic agents and the elderly |
| Q67489630 | Erythropoietin |
| Q86260187 | Erythropoietin |
| Q26999850 | Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefit |
| Q42637784 | Erythropoietin prevents chemotherapy-induced anemia: case report |
| Q83496270 | Erythropoietin processing in erythropoietic system and central nervous system |
| Q42797884 | Erythropoietin: recent developments in the treatment of spinal cord injury |
| Q36682779 | Functional significance of erythropoietin receptor on tumor cells |
| Q42879674 | Granulocyte/macrophage-, megakaryocyte-, eosinophil- and erythroid-colony-stimulating factors produced by mouse spleen cells |
| Q35044649 | Human alpha-fetoprotein as a modulator of human lymphocyte transformation: correlation of biological potency with electrophoretic variants |
| Q72667275 | In vivo activity of asialo-erythropoietin in combination with asialo-glycoproteins |
| Q42010530 | Investigation of purification process stresses on erythropoietin peptide mapping profile |
| Q57214487 | Novel recombinant feline interferon carrying N-glycans with reduced allergy risk produced by a transgenic silkworm system |
| Q42174090 | Recombinant human erythropoietin (rHuEPO): cross-linking with disuccinimidyl esters and identification of the interfacing domains in EPO. |
| Q34311306 | Relationship between sugar chain structure and biological activity of recombinant human erythropoietin produced in Chinese hamster ovary cells |
| Q37616294 | Renal mesangial cell cultures as a model for study of erythropoietin production |
| Q35196030 | Sequential activation of splenic nuclear RNA polymerases by erythropoietin |
| Q45958455 | The impact of glycosylation on the pharmacokinetics of a TNFR2:Fc fusion protein expressed in Glycoengineered Pichia Pastoris. |